Nelson Dusetti.

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Nelson Dusetti.
Jun 21, 2025, 08:57 | Blog
Nelson Dusetti: Predicting, Understanding, and Better Treating Pancreatic Cancer
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Jun 5, 2025, 05:09 | Science
Nelson Dusetti: Article on Medical Management of Pancreatic Cancer Just Accepted in Cancer Treatment Reviews
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Jun 2, 2025, 12:23 | Blog
Nelson Dusetti Announces Hiring for Pancreatic Cancer Research Engineer Role in Marseille
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre…
May 29, 2025, 15:41 | Blog
Meet The Translational and Therapeutic Research in Pancreatic Cancer Team at Cancer Research Centre of Marseille - AFRCP
French Association for Pancreatic Cancer Research shared a post on LinkedIn: "Meet the 'Translational and…
May 24, 2025, 19:12 | Blog
Nelson Dusetti: Hiring a Research Engineer to Join CRCM, IPC and INSERM in Marseille
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
May 23, 2025, 02:07 | Blog
Nelson Dusetti: Pancreas-View to Be Presented at Upcoming CFP Webinar
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
May 17, 2025, 10:22 | Science
Nelson Dusetti Shared New Article on E-cadherin's Function in Pancreatic Cancer Cell Invasion
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre…
May 15, 2025, 09:14 | Insight
Nelson Dusetti: SCHEMA-PDAC was selected for funding by the ARC French Foundation for Cancer Research
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre…
May 14, 2025, 12:34 | Science
Nelson Dusetti: The Use of Pancreas-View GEM to Personalize Adjuvant Chemotherapy and Improve Outcomes in PDAC
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre…
May 5, 2025, 14:24 | Insight
Nelson Dusetti: Advancing Pancreatic Cancer Research with ARARD Foundation
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Apr 17, 2025, 07:40 | Blog
Nelson Dusetti: Excited to announce the kick-off meeting of EU-funded project COMBAT-PDAC
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Apr 12, 2025, 11:17 | Blog
Nelson Dusetti: Honored to Be Invited to the Poor Prognosis Cancers: From Resignation to Revolution Conference
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Apr 4, 2025, 08:35 | Blog
Joseph Ciccolini: Proud to represent the Translational Research Department at the CRCM with Nelson Dusetti
Joseph Ciccolini, Chair of Pharmacology & Molecular Mechanisms Group, shared a post on LinkedIn: "Proud…
Mar 25, 2025, 11:05 | Blog
Nelson Dusetti: PANCprofiler - A step forward in personalizing pancreatic cancer treatment
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Mar 19, 2025, 09:10 | Blog
Nelson Dusetti: Identifying resistant pancreatic adenocarcinoma phenotypes with 'PANCprofiler'
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Mar 17, 2025, 10:46 | Blog
Nelson Dusetti: CRCM is looking for a postdoctoral researcher
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Mar 10, 2025, 15:53 | Blog
Nelson Dusetti: Honored to be a Keynote Speaker at the 45th EORTC-PAMM Conference
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Mar 9, 2025, 03:59 | Blog
Nelson Dusetti: Startups are essential in bridging scientific innovation and patient care
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research…
Mar 8, 2025, 08:42 | Blog
Scientific Breakfast with Nelson Dusetti
Regional Delegation Inserm Provence-Alpes-Côte d'Azur and Corsica posted on LinkedIn: "A look back at our…
Mar 3, 2025, 11:29 | Blog
Nelson Dusetti: Honored to present a seminar at ONCOLille Institute on Personalized Treatment for Pancreatic Cancer
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared…
Feb 17, 2025, 06:30 | Science
Nelson Dusetti: Investigating how the pancreatic tumor microenvironment affects γδ T cells
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared…
Feb 14, 2025, 10:29 | Blog
Marc Hilmi: The intratumoral heterogeneity of pancreatic ductal adenocarcinoma
Marc Hilmi, Chercheur postdoctoral at Memorial Sloan Kettering Cancer Center, shared a paper he and his…
Feb 11, 2025, 09:02 | Blog
Nelson Dusetti: The role of FKBP7 as a novel regulator of PSC activation and collagen remodeling in the PDAC
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared…
Feb 10, 2025, 17:17 | Blog
Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared…
Feb 2, 2025, 17:31 | Blog
Nelson Dusetti: Grateful for Canceropôle Provence-Alpes-Côte d'Azur support
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM shared…
Jan 6, 2025, 15:59 | Blog
Nelson Dusetti: Thrilled to visit IRCCS Ospedale San Raffaele
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM, shared a…
Dec 28, 2024, 13:46 | Blog
Nelson Dusetti: Transforming Pancreatic Cancer Treatment in 2024 - MediaMedic
MediaMedic shared a post on LinkedIn: "Dr. Nelson Dusetti: Transforming Pancreatic Cancer Treatment in 2024…
Dec 26, 2024, 06:29 | Insight
A European Project to Better Understand and Treat Pancreatic Cancer
Pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC), is one of the most aggressive and deadly…
Dec 23, 2024, 12:55 | Science
Nelson Dusetti: Our European project on pancreatic cancer
Nelson Dusetti, Research Director at INSERM, shared a post on LinkedIn about a recent article…
Dec 11, 2024, 09:32 | Insight
Nelson Dusetti: Our project COMBAT-PDAC has secured nearly 2 million euros in funding from the EP PerMed
Nelson Dusetti, Research Director at INSERM, shared a post on LinkedIn: "I am thrilled to…
Dec 6, 2024, 05:18 | Insight
Nelson Dusetti: A key step forward in Organoid-Based Drug Screening
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Dec 1, 2024, 21:26 | Blog
Nelson Dusetti: Nicolas Fraunhoffer and Brice Chanez have been awarded funding from Canceropôle Provence-Alpes-Côte d'Azur
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 25, 2024, 13:56 | Blog
Nelson Dusetti: The Second Franco-Argentine collaborative meeting on Pancreatic Cancer
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 23, 2024, 12:15 | Blog
Nelson Dusetti: Wearing the purple ribbon to support everyone affected by Pancreatic Cancer
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 23, 2024, 08:32 | Blog
Nelson Dusetti: Representing CRCM and The Institute Paoli-Calmettes at SAIC
Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM,…
Nov 10, 2024, 02:00 | Insight
Nelson Dusetti: The applicability of our signatures in predicting treatment sensitivity and resistance in PDAC patients
Nelson Dusetti, Scientific Director of the company Predicting Med(CSO) and Chair of TRANSLATE-IT CRCM, shared an…
Nov 6, 2024, 11:03 | Blog
Nelson Dusetti: Discussing Advancements and foster Argentina-France collaborations in pancreatic cancer research
Nelson Dusetti, Scientific Director at the company Predicting Med (CSO), shared a post on LinkedIn: ''I’m pleased…
Oct 27, 2024, 09:26 | Blog
Nelson Dusetti: Modeling the Intratumoral Dynamics of Pancreatic Cancer to Target Resistant Phenotypes
Nelson Dusetti shared a post on X: ''Modeling the Intratumoral Dynamics of Pancreatic Cancer to…
Oct 22, 2024, 16:07 | Blog
Nelson Dusetti: Franco-Argentine Workshop on Pancreatic Cancer Research
Nelson Dusetti, Chair of TRANSLATE-IT CRCM, shared a post on LinkedIn: "Excited to announce the…
Oct 18, 2024, 15:01 | Blog
Nelson Dusetti: The Institut Choiseul recognises Jean-Baptiste Jaussaud as one of the top 100 economic leaders of tomorrow
Nelson Dusetti shared a post by Jean-Baptiste Jaussaud, CEO Predicting Med, on LinkedIn, adding: "It’s an…
Oct 9, 2024, 09:34 | Blog
Nelson Dusetti: The importance of molecular signatures in the personalization of treatments for PDAC
Nelson Dusetti shared on LinkedIn: "We are pleased to announce the release of our article…
Oct 4, 2024, 16:05 | Blog
Developing 3D organoid models to better understand pancreatic cancer treatment resistence
Nelson Dusetti shared a post by Institute Paoli-Calmettes, on Linkedin: ''We are excited about the…
Sep 17, 2024, 19:39 | Blog
Nelson Dusetti: Is a la carte treatment possible for pancreatic adenocarcinoma?
Nelson Dusetti shared a post on LinkedIn: "Next week, an important event will take place in…
Sep 12, 2024, 17:36 | Insight
Nelson Dusetti: A major advancement in transcriptomic signatures for predicting treatment sensitivity in pancreatic cancer
Nelson Dusetti shared on LinkedIn: "We are thrilled to announce a major advancement in transcriptomic…
Sep 9, 2024, 10:07 | Insight
Nelson Dusetti: Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program
Nelson Dusetti shared on X: “Grateful to Institut National Du Cancer for funding through the PRT-K…
Sep 8, 2024, 14:51 | Blog
Nelson Dusetti: Understanding the cellular mechanisms that drive pancreatic cancer treatment resistance in advanced cases
Nelson Dusetti shared on LinkedIn: "We are deeply grateful to the National Cancer Institute  for awarding…
Sep 5, 2024, 15:09 | Blog
Nelson Dusetti: Promising therapeutic strategies for targeting mitochondrial metabolism in pancreatic cancer cells
Nelson Dusetti shared a post on LinkedIn: "Exciting new research from Pierre Cordelier’s team, which we…
Sep 1, 2024, 08:12 | Insight
Enhancing post - operative treatment for pancreatic ductal adenocarcinoma through AI
Nelson Dusetti posted on X: “We are very grateful to Davide Melisi for the thoughtful…
Aug 30, 2024, 15:30 | Insight
Davide Melisi: Predicting sensitivity to chemotherapeutic treatments in pancreatic cancer with AI
Davide Melisi, Associate Professor of Medical Oncology at University of Verona, shared a post on…
Aug 3, 2024, 12:34 | Blog
Nelson Dusetti: Summary of plenary lectures presented by our team at European Pancreatic Club congress
Nelson Dusetti posted on LinkedIn: "I would like to thank Mayoly Laboratories and the Club…
Jul 24, 2024, 22:22 | Insight
Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer
Nelson Dusetti shared a post on LinkedIn:  "We are thrilled to announce one of the…
Jul 20, 2024, 21:00 | Blog
Nelson Dusetti: We are grateful to INCa for funding our project - NeoPREDICT
Nelson Dusetti shared a post on LinkedIn:  . "We are grateful to INCa for funding…
Jul 13, 2024, 04:51 | Dialogues
ASCO24 Updates: Pancreas-View: AI-Powered Precision Medicine for Pancreatic Cancer Treatment
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 3, 2024, 07:07 | Blog
The Pancreatic Cancer Team Marseille at the European Pancreatic Club 2024
Nelson Dusetti, Director of Research at CRCM, shared on LinkedIn: "Proud and happy to have…
Jul 2, 2024, 16:08 | Blog
Nelson Dusetti: Clinic and Digital Personalized Medicine seminar at the University of Corte
Nelson Dusetti, Director of the Translational Research and Innovative Therapies department in Pancreatic Cancer team,…
Jun 22, 2024, 14:12 | Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
All: 56 Posts: 1 - 100
Special Coverage